MEDICAL BREAKTHROUGHS RESEARCH SUMMARY
|
|
- Bethanie Webb
- 1 years ago
- Views:
Transcription
1 MEDICAL BREAKTHROUGHS RESEARCH SUMMARY TOPIC: Training the Body to Fight Melanoma REPORT: 3823 BACKGROUND: Melanoma is the most dangerous form of skin cancer that can be hard to treat and fatal if not caught in the early stages. Skin cancer is caused by rapid, significant amounts of ultraviolet radiation from the sun or a tanning bed that damages skin cells and causes them to create cancerous growths on the skin. These growths are called melanomas and can also develop from moles on the skin. Fortunately, if melanoma is caught early, it is almost always curable. Doctors recommend always doing a self-exam after being exposed to high amounts of UV rays. A simple self-exam consists of checking yourself all over for any possible lesions or unusual new moles or growths and determine if there is any change in existing moles or growths. (Source: TREATMENT: There are many treatment options for varying levels of melanoma such as surgery and chemotherapy. Surgeries for melanoma aren t always major procedures. There is also a simple excision; where the melanomas are removed along with some skin around the edges. For chemotherapy, success in melanoma cases has been limited. Dacarbazine is currently the only chemotherapy treatment that s been FDA approved to treat stage IV melanoma and is given as an intravenous infusion. (Source: NEW TECHNOLOGY: There may now be a better way to treat cases of melanoma. Immunotherapy is being tested on melanoma cases to see if doctors can turn a person s T cells into a weapon against skin cancer. T cells are the cells that carry out the function of the immune system. Immunotherapy uses medications to train a person s immune system to fight cancer cells and has so far shown promising results. T cells are first killed off in the body using chemotherapy and newly modified T cells are inserted. These new cells provide a more natural way for the body to fight melanoma. (Source: FOR MORE INFORMATION ON THIS REPORT, PLEASE CONTACT: Jim Ritter Media Relations Loyola University Medical Center If this story or any other Ivanhoe story has impacted your life or prompted you or someone you know to seek or change treatments, please let us know by contacting Marjorie Bekaert Thomas at
2 Michael Nishimura, Ph.D., Professor in the Department of Surgery and Associate Director of the Oncology Institute, Loyola Cardinal Bernardin Cancer Center, Loyola University in Chicago, School of Medicine. So tell me then about this gene therapy and how exactly it works. Dr. Nishimura: We isolate cells from a cancer patient and genetically modify them with specific genes which allow those immune cells to recognize the tumors. It gives them the specificity or reactivity and allows them to recognize targets on the cancer. And so for those at home, maybe that don t know the T-cells are fighter cells, can you clarify? Dr. Nishimura: Yes, they re white blood cells. They re part of your blood and when you get the flu; they become activated to fight flu virus infected cells and there are some in your body that can fight cancer cells. We actually engineer the cells to make them work better, so that they can target your cancer cells; which is harder to do naturally. Why the chemotherapy after you remove the cells and genetically alter them? Dr. Nishimura: There are two reasons for that. First, if you look at your blood, you have a normal level of white blood cells and when you deplete the white blood cells, there are signals which cause the ones that remain to grow and occupy the space. When we put these gene modified cells into somebody that s had the chemotherapy, the goal is for them to expand quite a bit in the patient so that they can go and fight the tumor. The second reason is there are many cells in your blood which can suppress the immune response against cancer. By depleting them first, we get rid of those negative cells; those cells that suppress, so we hope that the cells we put in expand and they function in a better environment. And then once those cells are in place, they re basically like a trained army and it s going to attack Dr. Nishimura: Basically that s correct. They are already genetically programmed to fight the cancer. How s that been working so far on the trial? Dr. Nishimura: I ve treated two patients; one unfortunately did not respond and one has a fairly nice clinical response. There s a number that we ve screened that weren t eligible for a variety of
3 reasons. They didn t meet the eligibility criteria, but there are also a lot of other therapies that are out there that compete for this trial. When did the trial start? Dr. Nishimura: About a year ago. Who would be best for this trial? Dr. Nishimura: The patient has to have advanced melanoma. Their tumors have to express the target that we re going after and the target is an enzyme which makes the pigment in melanoma. They have to have certain health characteristics. They can t have brain metastases. One of the patients that we screened turned out to have brain metastases and became ineligible. We don t want bleeding in the brain as a result of the therapy. So, there s a large entry criteria for it. You said this you re looking for a certain enzyme. Is it the most common? Dr. Nishimura: Yes it was surprising that this patient didn t have it in his tumor. Most of the melanomas express it. If the melanomas are black and most of them are, they express this protein. I was surprised. We came up with this from last year s work. Can you get more into the science of what you look for? Dr. Nishimura: There are specific proteins on the surface of a T-cell, a white blood cell, which tells it what targets to recognize. Again with the flu example, when you get the flu, you know the doctors look for swelling in your glands and in your underarms, you know? It s because your immune system is expanding and those cells that have the right proteins on the white blood cells which can recognize the flu are the ones that are expanding. So the idea is to take genes that encode those proteins from a cell that we know can target melanoma or any other cancer or virus for that matter, and transfer it to somebody else s cells. I could take your cells or anybody s cells and transfer that protein and that receptor will target the melanoma cells. That s how we do it. It s almost like using snake venom to make anti-venom, almost. Dr. Nishimura: Not quite, because it s more like taking the antibodies from a patient that is immune to the snake venom and transferring it to somebody else. We re basically engineering somebody s cells. In this case, this patient s cells with proteins that enable that cell to recognize the cancer. We re modifying their cells. How big of a breakthrough would you say this is then? Dr. Nishimura: Well there are a lot of trials that are out there doing this. We were the first ones to demonstrate that it was feasible in the laboratory, but Steven Rosenberg and others have done similar trials. This is new for Loyola. This is a new receptor. It s a new target and we re excited about it. We spent a lot of years developing this. We cloned this receptor almost 15 years ago and we ve done a lot of work to make sure that it s going to be safe. We already know
4 in animal models about the effectiveness and things like that. We want to make sure that we know as much as we could about this receptor before we ever put it into a patient. In some of the animal models, what were some of the stats? Dr. Nishimura: In some of our animal models, we can eliminate fairly large melanomas, both mass tumors and human tumor with T-cells that express this protein. Adoptive cell therapy is now becoming very exciting because this is a class of receptors like the chimeric antibody receptors out there, which have shown great promise in lymphomas. I think what it is now, is we re learning better how to use these cells; where before we weren t quite as knowledgeable about their biology and how to use them effectively in people. I think it s only going to get better in time and you can tell there is excitement because large pharmaceutical companies are starting to invest very heavily in this technology with a goal of commercializing these types of cells. Any idea how long a person would need to stay on this therapy before they start? Dr. Nishimura: In our trial, they get one single infusion; one single injection of cells. So the patient that you talked to, it was eight weeks ago and last time we checked which was a week or so ago, he still had three, four or five percent of the cells of his blood that were engineered cells and hopefully they will stay long term. The power of the immune system is its long term. When you are young; you get vaccinated for things, right? You don t have to get vaccinated again because your immune cells have memory that s different than chemotherapy. These cells potentially could be there for years. They could be there as long as he s alive; which we hope is going to be a long time. Was there anything to show how long life is prolonged, in the animal models? Dr. Nishimura: Well in animal models you can cure some mice with it. Mice live a year and a half to 2 years and months after there is no evidence of disease or of the tumor. In patient s it s hard to know what would happen to a patient if you don t treat them. My understanding was that when you re in stage IV melanoma was that you re pretty much at the end. Dr. Nishimura: In the old days that was true, but there are new therapies. There are new immune therapies that are showing great promise and that s one of the reasons it takes some time to enroll in experimental therapies. There are new FDA approved agents that have an impact on melanoma. They don t cure all of them and that s why we re still working to develop new therapies for this disease. This approach can work for other kinds of cancers as well. It doesn t have to be melanoma. We have other receptors that we re working with that we re headed toward putting into patients.
5 This information is intended for additional research purposes only. It is not to be used as a prescription or advice from Ivanhoe Broadcast News, Inc. or any medical professional interviewed. Ivanhoe Broadcast News, Inc. assumes no responsibility for the depth or accuracy of physician statements. Procedures or medicines apply to different people and medical factors; always consult your physician on medical matters. If you would like more information, please contact Michael Nishimura, Ph.D. Associate Director of Oncology Institute Professor of Surgery Loyola University Chicago Sign up for a free weekly on Medical Breakthroughs called First to Know by clicking here.
MEDICAL BREAKTHROUGHS RESEARCH SUMMARY
TOPIC: PROTON THERAPY FOR KIDS REPORT: MB #3912 MEDICAL BREAKTHROUGHS RESEARCH SUMMARY BACKGROUND: Every year about 13,500 children are diagnosed with some form of cancer in the United States. Currently
Monoclonal Antibody Therapy: Innovations in Cancer Treatment. James Choi ENGL 202C
Monoclonal Antibody Therapy: Innovations in Cancer Treatment James Choi ENGL 202C Treating Cancer with Monoclonal Antibody Therapy Researchers and scientists have been working for decades to find a cure
Biological Therapies for Cancer
Biological Therapies for Cancer Key Points Biological therapies use the body's immune system to fight cancer or to lessen the side effects that may be caused by some cancer treatments. Biological therapies
What You Need to Know About Lung Cancer Immunotherapy
What You Need to Know About Lung Cancer Immunotherapy Lung.org/immunotherapy What is immunotherapy? Immunotherapy for cancer, sometimes called immune-oncology, is a type of medicine that treats cancer
MEDICAL BREAKTHROUGHS RESEARCH SUMMARY
TOPIC: Using Video to Kill Lung Cancer REPORT: MB #4111 MEDICAL BREAKTHROUGHS RESEARCH SUMMARY BACKGROUND: Lung cancer is the second most common cancer in both men and women, excluding skin cancer. About
CAR T Cell Immunotherapy A LIVING DRUG TO FIGHT CANCER
CAR T Cell Immunotherapy A LIVING DRUG TO FIGHT CANCER One new cancer treatment being studied is CAR T cell (Chimeric Antigen Receptor T cell) therapy. CAR T cell therapy uses a patient s own cells and
MEDICAL BREAKTHROUGHS RESEARCH SUMMARY TOPIC: MAMMOGRAM FOR THE HEART: CORONARY CALCIUM SCORE REPORT: MB #4014
MEDICAL BREAKTHROUGHS RESEARCH SUMMARY TOPIC: MAMMOGRAM FOR THE HEART: CORONARY CALCIUM SCORE REPORT: MB #4014 BACKGROUND: Heart disease is a term that can refer to several types of heart conditions. Coronary
Metastatic Melanoma What You Need to Know
ESSENTIALS Metastatic Melanoma Metastatic Melanoma What You Need to Know If you have metastatic melanoma, you may feel as though your life has been turned upside down. It s a serious disease, but patients
MEDICAL BREAKTHROUGHS RESEARCH SUMMARY
TOPIC: DIPG: SEARCH FOR A CURE REPORT: MB #4013 MEDICAL BREAKTHROUGHS RESEARCH SUMMARY BACKGROUND: Diffuse Intrinsic Pontine Glioma, known as DIPG, is a highly aggressive brain tumor that accounts for
Recruiting now. Could you help by joining this study?
Non-Small Cell Lung Cancer Recruiting now AstraZeneca is looking for men and women with locally advanced or metastatic non-small cell lung cancer (NSCLC) to join ATLANTIC, a clinical study to help investigate
Jeffrey Dunn, MD, a clinical neuro-immunologist at Stanford School of Medicine talks about a new oral option for MS patients.
Say Ahh! The First Oral Treatment for MS Jeffrey Dunn, MD Jeffrey Dunn, MD, a clinical neuro-immunologist at Stanford School of Medicine talks about a new oral option for MS patients. Are you seeing more
Your Immune System & Cancer Treatment
Your Immune System & Cancer Treatment Immunotherapy Today, immunotherapy is one of the most exciting areas of new discoveries and treatments for many different kinds of cancer. Researchers now know that
The Role of Gene Therapy in Cancer Treatment. Rehan Mujahid. Abstract
The Role of Gene Therapy in Cancer Treatment Rehan Mujahid Abstract Cancer is one of the major diseases in the world. This paper explores the biology of cancer cells and explains how they are originated.
immunotherapy a guide for the patient
immunotherapy FOR LUNG CANCER a guide for the patient TABLE OF CONTENTS lung cancer basics... 2 immunotherapy... 5 Monoclonal Antibodies... 6 Vaccines... 7 Adoptive T-Cell Transfer... 8 Oncolytic Viruses...
I was just diagnosed, so my doctor and I are deciding on treatment. My doctor said there are several
Track 3: Goals of therapy I was just diagnosed, so my doctor and I are deciding on treatment. My doctor said there are several factors she ll use to decide what s best for me. Let s talk about making treatment
We want to keep prostate cancer from coming back. We re looking for 711 men who want to help.
We want to keep prostate cancer from coming back. We re looking for 711 men who want to help. IMPORTANT INFORMATION FOR PROSTATE CANCER PATIENTS The odds are already in your favor. If you have been diagnosed
Immune cells from healthy people pulverise cancer
Published on ScienceNordic (http://sciencenordic.com) Home > Printer-friendly PDF > Printer-friendly PDF Immune cells from healthy people pulverise cancer Health[1] Health[1]Cancer research [2]immune system
Individualizing Your Lung Cancer Care: Informing Decisions Through Biomarker Testing
Individualizing Your Lung Cancer Care: Informing Decisions Through Biomarker Testing These Are Hopeful Times for Lung Cancer Survivors When people first learn they have cancer, they are often afraid. But
Understanding series. new. directions. 1-800-298-2436 LungCancerAlliance.org. A guide for the patient
Understanding series LUNG CANCER: new treatment directions 1-800-298-2436 LungCancerAlliance.org A guide for the patient TABLE OF CONTENTS What s New in lung cancer? Advancements...4 Changes in genes that
Your Immune System & Melanoma Treatment
Your Immune System & Melanoma Treatment Immunotherapy and Melanoma Immunotherapy is rapidly emerging as an important approach to treating many forms of cancer. For people with melanoma, the news is particularly
RADIATION THERAPY FOR LYMPHOMA. Facts to Help Patients Make an Informed Decision TARGETING CANCER CARE AMERICAN SOCIETY FOR RADIATION ONCOLOGY
RADIATION THERAPY FOR Facts to Help Patients Make an Informed Decision TARGETING CANCER CARE AMERICAN SOCIETY FOR RADIATION ONCOLOGY FACTS ABOUT The lymphatic system is a network of tiny vessels extending
Lauren Berger: Why is it so important for patients to get an accurate diagnosis of their blood cancer subtype?
Hello, I m Lauren Berger and I m the Senior Director of Patient Services Programs at The Leukemia & Lymphoma Society. I m pleased to welcome Dr. Rebecca Elstrom. Dr. Elstrom is an Assistant Professor in
Breakthrough Lung Cancer Treatment Approved Webcast September 9, 2011 Renato Martins, M.D., M.P.H. Introduction
Breakthrough Lung Cancer Treatment Approved Webcast September 9, 2011 Renato Martins, M.D., M.P.H. Please remember the opinions expressed on Patient Power are not necessarily the views of Seattle Cancer
CANCER TREATMENT: Chemotherapy
CANCER TREATMENT: Chemotherapy Chemotherapy, often called chemo, is the use of drugs to treat a disease. The term chemotherapy is now most often used to describe a type of cancer treatment. Dr. Khuri:
Treating Melanoma S kin Cancer A Quick Guide
Treating Melanoma Skin Cancer A Quick Guide Contents This is a brief summary of the information on Treating melanoma skin cancer from our website. You will find more detailed information on the website.
Biological Therapies for Cancer: Questions and Answers. Key Points
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Biological Therapies for
Multiple Myeloma. This reference summary will help you understand multiple myeloma and its treatment options.
Multiple Myeloma Introduction Multiple myeloma is a type of cancer that affects white blood cells. Each year, thousands of people find out that they have multiple myeloma. This reference summary will help
Understanding How Existing and Emerging MS Therapies Work
Understanding How Existing and Emerging MS Therapies Work This is a promising and hopeful time in the field of multiple sclerosis (MS). Many new and different therapies are nearing the final stages of
Melanoma/Skin Cancer. What is the Impact on Hoosiers? Table 9. Burden of Melanoma Indiana, Average number of cases per year ( )
What is the Impact on Hoosiers? Table 9. Burden of Melanoma Indiana, 2004 2008 Average number of cases per year (2004 2008) Rate per 100,000 people* (2004 2008) Number of cases (2008) Rate per 100,000
Malignant Melanoma Early Stage. A guide for patients
This melanoma patient brochure is designed to help educate melanoma patients and their caregivers. It was developed under the guidance of Dr. Michael Smylie, Professor, Department of Oncology, University
Ask Us About Clinical Trials
Ask Us About Clinical Trials Clinical Trials and You. Our specialists and researchers are at the forefront of their fields and are leading the way in developing new therapies and procedures for diagnosing
Top Ten Things to Know About Stem Cell Treatments
Top Ten Things to Know About Stem Cell Treatments Many clinics that are offering stem cell treatments make claims about what stem cells can and cannot do that are not supported by our understanding of
Dr. Martins, as I say, there is progress being made. How would you describe it now when it comes to lung cancer?
1 November 28, 2007 State-of-the-art Lung Cancer Treatments Renato Martins, M.D., Hosted by Andrew Schorr Please remember the opinions expressed on Patient Power are not necessarily the views of Seattle
Update in Hematology Oncology Targeted Therapies. Mark Holguin
Update in Hematology Oncology Targeted Therapies Mark Holguin 25 years ago Why I chose oncology People How to help people with possibly the most difficult thing they may have to deal with Science Turning
Breakthrough Treatment Options for Breast Cancer
Breakthrough Treatment Options for Breast Cancer Guest Expert: Lyndsay, MD Associate Professor of Medical Oncology, Yale Cancer Center www.wnpr.org www.yalecancercenter.org Welcome to Yale Cancer Center
IMMUNOTHERAPY FOR THE TREATMENT OF LUNG CANCER
IMMUNOTHERAPY FOR THE TREATMENT OF LUNG CANCER BOOKLET SUPPLEMENT Immunotherapy Immunotherapy is one of the most exciting new approaches for treating several types of cancer, including lung cancer. Immunotherapies
Understanding Cancer With Dr. Fox: An Activity Book
Understanding Cancer With Dr. Fox: An Activity Book By The 8 th Grade Students of The Riverside School Hello kids! My name is Dr. Fox. The students in The Riverside School's 8th grade and I are going to
NEW CLINICAL RESEARCH OPTIONS IN PANCREATIC CANCER IMMUNOTHERAPY. Alan Melcher Professor of Clinical Oncology and Biotherapy Leeds
NEW CLINICAL RESEARCH OPTIONS IN PANCREATIC CANCER IMMUNOTHERAPY Alan Melcher Professor of Clinical Oncology and Biotherapy Leeds CANCER IMMUNOTHERAPY - Breakthrough of the Year in Science magazine 2013.
What is Cancer? Pediatric Oncologist. What is Cancer? A doctor who takes care of kids with cancer
Public Education Seminar Community Outreach Program January 27th, 2010 What is Cancer? Introduced by Aubrey Van Kirk What is Cancer? Patrick Campbell, MD, PhD Department of Oncology St. Jude Children s
Your Immune System & Lung Cancer Treatment
Your Immune System & Lung Cancer Treatment Immunotherapy and Lung Cancer Immunotherapy is quickly developing as an important approach to treating many forms of cancer, including lung cancer. Immunotherapy
Breast Cancer. CSC Cancer Experience Registry Member, breast cancer
ESSENTIALS Breast Cancer Take things one step at a time. Try not to be overwhelmed by the tidal wave of technical information coming your way. Finally you know your body best; you have to be your own advocate.
Metastatic Cancer: Questions and Answers. Key Points
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Metastatic Cancer: Questions
What is a Stem Cell Transplantation?
What is a Stem Cell Transplantation? Guest Expert: Stuart, MD Associate Professor, Medical Oncology www.wnpr.org www.yalecancercenter.org Welcome to Yale Cancer Center Answers with Drs. Ed and Ken. I am
1400 Telegraph Bloomfield Hills, MI 48302 248-334-6877-Phone number/248-334-6877-fax Number CANCER TREATMENT
1400 Telegraph Bloomfield Hills, MI 48302 248-334-6877-Phone number/248-334-6877-fax Number CANCER TREATMENT Learning that your pet has a diagnosis of cancer can be overwhelming. We realize that your pet
Starting treatment early with PERJETA
Starting treatment early with PERJETA A TREATMENT FOR HER2-POSITIVE EARLY BREAST CANCER GIVEN BEFORE SURGERY HER2 = human epidermal growth factor receptor 2. What does PERJETA treat? PERJETA (pertuzumab)
RADIATION THERAPY FOR BRAIN METASTASES. Facts to Help Patients Make an Informed Decision TARGETING CANCER CARE AMERICAN SOCIETY FOR RADIATION ONCOLOGY
RADIATION THERAPY FOR BRAIN METASTASES Facts to Help Patients Make an Informed Decision TARGETING CANCER CARE AMERICAN SOCIETY FOR RADIATION ONCOLOGY FACTS ABOUT BRAIN METASTASIS Brain metastases are clusters
Prostate Cancer Guide. A resource to help answer your questions about prostate cancer
Prostate Cancer Guide A resource to help answer your questions about prostate cancer Thank you for downloading this guide to prostate cancer treatment. We know that all the information provided online
Mutations: 2 general ways to alter DNA. Mutations. What is a mutation? Mutations are rare. Changes in a single DNA base. Change a single DNA base
Mutations Mutations: 2 general ways to alter DNA Change a single DNA base Or entire sections of DNA can move from one place to another What is a mutation? Any change in the nucleotide sequence of DNA Here
Biologic Treatments for Rheumatoid Arthritis
Biologic Treatments Rheumatoid Arthritis (also known as cytokine inhibitors, TNF inhibitors, IL 1 inhibitor, or Biologic Response Modifiers) Description Biologics are new class of drugs that have been
SKIN CANCER AND TANNING 101. Introduction. There are more than one hundred types of cancer. All the kinds of cancer begin in our cells.
Introduction There are more than one hundred types of cancer. All the kinds of cancer begin in our cells. Normal cells grow and multiply and then die. Cancer cells grow and multiply and keep growing and
Fact Sheet: Molecular Imaging and Cancer
Fact Sheet: Molecular Imaging and Cancer Cancer causes one in every four deaths in the United States, second only to heart disease. According to the American Cancer Society, an estimated 1.48 million new
The Treatment of Leukemia
The Treatment of Leukemia Guest Expert: Peter, MD Associate Professor of Hematology Director, Yale Cancer Center Leukemia Program www.wnpr.org www.yalecancercenter.org Hi, I am Bruce Barber and welcome
Smoking and misuse of certain pain medicines can affect the risk of developing renal cell cancer.
Renal cell cancer Renal cell cancer is a disease in which malignant (cancer) cells form in tubules of the kidney. Renal cell cancer (also called kidney cancer or renal adenocarcinoma) is a disease in which
Molecular Imaging and Prostate Cancer
Molecular Imaging and Prostate Cancer Prostate cancer is the second leading cause of cancer death in American men, behind only lung cancer. Based on rates from 2004 2006, the National Cancer Institute
Clinical Trials. Clinical trials the basics
Clinical Trials Clinical Trials This brochure is for people making decisions about cancer treatment. You may be thinking about a clinical trial for you or your child but need to know more before you decide.
Bone Marrow Transplantation
Bone Marrow Transplantation Introduction Bone marrow is the spongy tissue inside all of your bones, including your hip and thigh bones. The bone marrow is like a factory that makes different types of blood
Narrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood
[Track 2: What Is a Transplant?] Narrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood can be an effective treatment for people with blood cancers such as leukemia,
Clinical Trials: What You Need to Know
Clinical Trials: What You Need to Know Clinical trials are studies in which people volunteer to test new drugs or devices. Doctors use clinical trials to learn whether a new treatment works and is safe
Many people with non-hodgkin lymphoma have found an educational support group helpful. Support
Track 2: Treatment Options [Narrator] Many people with non-hodgkin lymphoma have found an educational support group helpful. Support groups take many forms: some meet the needs of people with all kinds
Adjuvant Therapy for Breast Cancer: Questions and Answers
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Adjuvant Therapy for Breast
RESEARCH EDUCATE ADVOCATE. Just Diagnosed with Melanoma Now What?
RESEARCH EDUCATE ADVOCATE Just Diagnosed with Melanoma Now What? INTRODUCTION If you are reading this, you have undergone a biopsy (either of a skin lesion or a lymph node) or have had other tests in which
Innovations in Head and Neck Cancer
Innovations in Head and Neck Cancer Guest Expert: Hari Deshpande, MD Assistant Professor of Medical Oncology www.wnpr.org www.yalecancercenter.org Welcome to Yale Cancer Center Answers with Drs. Ed Chu
Malignant Melanoma. Exceptional healthcare, personally delivered
Malignant Melanoma Exceptional healthcare, personally delivered What is malignant melanoma?. Malignant melanoma is a form of skin cancer which can start in a pre-existing mole or normal looking skin. What
Asymptomatic or smoldering myeloma with no symptoms and slow growing cancer cells
ESSENTIALS Multiple Myeloma Diagnosed with Multiple Myeloma? It s important to understand everything you can about your diagnosis, possible treatments, and places to go for support and care. Cancer is
Immuno-Oncology Therapies to Treat Lung Cancer
Immuno-Oncology Therapies to Treat Lung Cancer What you need to know ONCHQ14NP07519 Introduction: Immuno-oncology represents an innovative approach to cancer research that seeks to harness the body s own
Cancer Clinical Trials
Cancer Clinical Trials The Basic Workbook National Institutes of Health National Cancer Institute The National Cancer Institute Clinical Trials Education Series Cancer Clinical Trials Books Cancer Clinical
MS Learn Online Feature Presentation Understanding MS Research Robert Lisak, MD. Tom>> And I'm Tom Kimball. Welcome to MS Learn Online.
Tracey>> Hi I'm Tracey Kimball MS Learn Online Feature Presentation Understanding MS Research Robert Lisak, MD Tom>> And I'm Tom Kimball. Welcome to MS Learn Online. Tracey>> There's so much to learn when
A handbook for people who have injected drugs
A handbook for people who have injected drugs Introduction This handbook has been written for current and ex-drug injectors. It gives information and advice about the hep C virus, and the tests you can
Understanding CA 125 Levels A GUIDE FOR OVARIAN CANCER PATIENTS. foundationforwomenscancer.org
Understanding CA 125 Levels A GUIDE FOR OVARIAN CANCER PATIENTS foundationforwomenscancer.org Contents Introduction...1 CA 125................................... 1 The CA 125 Test...2 The Use of the CA
Biologics Biosimilars
Biologics Biosimilars Q u e st i o n s Po l i c y S a fe t y What are biosimilars? Biosimilars are sometimes incorrectly and inappropriately called generic versions of original biological medicines. But
M6-1 NOTE. Each major learning point is clearly identified by boldface type throughout the guide and emphasized in the PowerPoint presentation.
Basics of Cancer Treatment Module 6 Basics of Cancer Treatment Target Audience: Community members Staff of Indian health programs, including Community Health Representatives Contents of Learning Module:
Name Date Class. This section explains what kinds of organisms cause infectious disease and how infectious diseases are spread.
Fighting Disease Name Date Class Infectious Disease This section explains what kinds of organisms cause infectious disease and how infectious diseases are spread. Use Target Reading Skills Before you read,
Species at war. Information sheets and question sheets. Science: Biology. Microorganisms, pathogens and the body s defences.
Species at war Information sheets and question sheets Subject(s): Science: Biology Age group(s): 12 14 Topic(s): Microorganisms, pathogens and the body s defences Source This resource was originally developed
APA format (title page missing) Proton Therapy 3. A paper. A New Cancer Treatment: Proton Therapy. A Review of the Literature
APA format (title page missing) Proton Therapy 3 A paper A New Cancer Treatment: Proton Therapy A Review of the Literature Cancer is a widespread disease that is defined as a malignant or invasive growth
When to Consider Liver Transplantation for Patients with Hepatitis C
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/advances-in-transplantation/when-to-consider-liver-transplantation-forpatients-with-hepatitis-c/6366/
Blood & Marrow Transplant Glossary. Pediatric Blood and Marrow Transplant Program Patient Guide
Blood & Marrow Transplant Glossary Pediatric Blood and Marrow Transplant Program Patient Guide Glossary Absolute Neutrophil Count (ANC) -- Also called "absolute granulocyte count" amount of white blood
This information explains the advice about skin cancer (melanoma) that is set out in NICE guideline NG14.
Information for the public Published: 29 July 2015 nice.org.uk About this information NICE guidelines provide advice on the care and support that should be offered to people who use health and care services.
Melanoma. Understanding your diagnosis
Melanoma Understanding your diagnosis Melanoma Understanding your diagnosis When you first hear that you have cancer, you may feel alone and afraid. You may be overwhelmed by the large amount of information
Immunotherapy of Uveal Melanoma
Eye Am Not Alone (EANA) Patient Retreat Saturday Session - March 3, 2012 Immunotherapy of Uveal Melanoma Do not distribute or copy without the express permission of the Ocular Melanoma Foundation (OMF).
Clinical Trials: Improving the Care of People Living With Cancer
CLINICAL TRIALS Clinical Trials: Improving the Care of People Living With Cancer Presented by Mary McCabe, RN, MA Memorial Sloan-Kettering Cancer Center Carolyn Messner, DSW CancerCare Learn about: Stages
Stem Cell Quick Guide: Stem Cell Basics
Stem Cell Quick Guide: Stem Cell Basics What is a Stem Cell? Stem cells are the starting point from which the rest of the body grows. The adult human body is made up of hundreds of millions of different
MEDICAL BREAKTHROUGHS RESEARCH SUMMARY
MEDICAL BREAKTHROUGHS RESEARCH SUMMARY TOPIC: STEM CELLS FOR SPORTS INJURIES REPORT: MB # 3975 BACKGROUND: Sports injuries can occur during any sports or exercise activities. The term typically refers
Increasing Patient Access through Oral Parity Legislation
Increasing Patient Access through Oral Parity Legislation The Leukemia & Lymphoma Society A powerhouse among nonprofits searching for cancer cures Our Mission; Cure leukemia, lymphoma, Hodgkin s disease
Beyond Traditional Treatments for Lung Cancer: The Roles of Molecular Medicine and Individualized Therapies (Video Transcript)
Beyond Traditional Treatments for Lung Cancer: The Roles of Molecular Medicine and Individualized Therapies (Video Transcript) To view the accompanying video of this transcript and to download a PDF of
Hosts. Melanoma Awareness Yale Cancer Center Answers is a weekly broadcast on WNPR Connecticut Public Radio Sunday evenings at 6:00 PM.
Hosts Anees MD Associate Professor of Surgical Oncology Francine Foss MD Professor of Hematology Steven Gore MD Director of Hematological Malignancies Melanoma Awareness 2014 Guest Experts: Dale, MD Assistant
Objectives: Immunity Gone Wrong: Autoimmune Diseases in Dental Hygiene Practice
Objectives: 1) Understand the concept of self- tolerance versus non- self- tolerance. 2) Recognize systemic and oral indicators of autoimmune diseases. 3) Identify various autoimmune diseases and their
WHEN PROSTATE CANCER RETURNS: ADVANCED PROSTATE CANCER. How Will I Know If My Prostate Cancer Returns?
WHEN PROSTATE CANCER RETURNS: ADVANCED PROSTATE CANCER (The following information is based on the general experiences of many prostate cancer patients. Your experience may be different.) How Will I Know
Clinical Trials. I didn t know anything about clinical trials. I d never been in one before and just never thought of it. ~ Albert
Clinical Trials Clinical Trials This brochure is for people making decisions about cancer treatment. You may be thinking about a clinical trial for you or your child but need to know more before you decide.
PROSTATE CANCER 101 WHAT IS PROSTATE CANCER?
PROSTATE CANCER 101 WHAT IS PROSTATE CANCER? Prostate cancer is cancer that begins in the prostate. The prostate is a walnut-shaped gland in the male reproductive system located below the bladder and in
Radiation Therapy for Cancer Treatment
Radiation Therapy for Cancer Treatment Guest Expert: Kenneth, MD Associate Professor of Therapeutic Radiology www.wnpr.org www.yalecancercenter.org Welcome to Yale Cancer Center Answers with Dr. Ed and
The Center for Prostate Cancer. Personalized Treatment. Clinical Excellence.
The Center for Prostate Cancer Personalized Treatment. Clinical Excellence. The Center for Prostate Cancer Leaders in Prostate Cancer Treatment and Research The Center for Prostate Cancer at the North
Foundational Issues Related to Immunotherapy and Melanoma
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
Chugai Pharmaceutical Co., Ltd. Oncology Area, Scientific Group 2, Breast Cancer Group Takehiro Yamaguchi, Herceptin Product Manager
Anti-malignant Tumor Agent with Anti-HER2 Humanized Monoclonal Antibody: Biologics, Designated drug, Prescription drug HERCEPTIN Injection 60 HERCEPTIN Injection 150 Trastuzumab (genetical recombination)
Brain Tumor Treatment
Scan for mobile link. Brain Tumor Treatment Brain Tumors Overview A brain tumor is a group of abnormal cells that grows in or around the brain. Tumors can directly destroy healthy brain cells. They can
Innovations in Kidney Cancer
Innovations in Kidney Cancer Guest Expert: Harriet, MD Associate Professor of Medical Oncology Edward, MD Assistant Professor of Surgical Urology www.wnpr.org www.yalecancercenter.org Welcome to Yale Cancer
Surgery. Wedge resection only part of the lung, not. not a lobe, is removed. Cancer Council NSW
The treatment you receive will depend on your lung cancer type, for example, whether you have a non-small cell lung cancer Adenocarcinoma or Squamous cell carcinoma, and if this is a sub-type with a mutation.
What You Need to Know About LEMTRADA (alemtuzumab) Treatment: A Patient Guide
For Patients What You Need to Know About LEMTRADA (alemtuzumab) Treatment: A Patient Guide Patients: Your doctor or nurse will go over this patient guide with you. It is important to ask any questions
Where World-Class Expertise and Genuine Compassion Come Together. AT THE FOREFRONT OF TRANSPLANT CARE Kidney Combined Kidney-Pancreas Pancreas Islets
Where World-Class Expertise and Genuine Compassion Come Together 0011000110100111100110111100000101010011000101100010111000010010000100010000100001011110101010101111000 000010111000101110011000110100111100110111100000101010011000101100010111000010010000100010000100
Advanced Prostate Cancer Treatments
Advanced Prostate Cancer Treatments Guest Expert: Kevin, DO Associate Professor of Medical Oncology, Yale Cancer Center www.wnpr.org www.yalecancercenter.org Welcome to Yale Cancer Center Answers with
The immune system. Bone marrow. Thymus. Spleen. Bone marrow. NK cell. B-cell. T-cell. Basophil Neutrophil. Eosinophil. Myeloid progenitor
The immune system Basophil Neutrophil Bone marrow Eosinophil Myeloid progenitor Dendritic cell Pluripotent Stem cell Lymphoid progenitor Platelets Bone marrow Thymus NK cell T-cell B-cell Spleen Cancer